Ignite Creation Date:
2025-12-25 @ 4:02 AM
Ignite Modification Date:
2026-02-22 @ 3:58 AM
Study NCT ID:
NCT02470702
Status:
COMPLETED
Last Update Posted:
2023-12-19
First Post:
2015-05-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Multiple Oritavancin Doses on Safety, Tolerability, and Pharmacokinetics in Healthy Subjects
Sponsor:
Melinta Therapeutics, Inc.
Organization: